Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Gerlach

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Complementary Medicine Research|July 30, 2023
Improvement of Spinocerebellar Ataxia 3 Symptoms Treated with Eurythmy Therapy: A Case VignetteKatharina Gerlach
Complementary Therapies in Medicine|May 26, 2019
Development of a documentation instrument for movement-orientated Mind-Body-Therapies taking the example of Eurythmy-TherapyKatharina Gerlach, Daniela Rodrigues Recchia, Arndt Büssing
Tissue Barriers|April 4, 2015
IL-9 regulates intestinal barrier function in experimental T cell-mediated colitisKatharina Gerlach, Andrew N McKenzie, Markus F Neurath, et al.
International Journal of Cancer|June 19, 2013
Nuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerCarolin Daniel, Katharina Gerlach, Martin Väth, et al.
Developmental Psychology|June 27, 2017
The role of morbidity for proxy-reported well-being in the last year of lifeKatharina Gerlach, Nilam Ram, Frank J Infurna, et al.
Nature Protocols|June 2, 2017
Chemically induced mouse models of acute and chronic intestinal inflammationStefan Wirtz, Vanessa Popp, Markus Kindermann, et al.
Cancer Research|June 29, 2012
Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitisKatharina Gerlach, Carolin Daniel, Hans A Lehr, et al.
Plos One|January 18, 2019
FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiationMarlene Steiner, Lucas Schneider, Jasmin Yillah, et al.
Journal of Crohn'S & Colitis|August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammationKatharina Gerlach, Kristina Lechner, Vanessa Popp, et al.
Gastroenterology|September 19, 2016
Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in MiceVanessa Popp, Katharina Gerlach, Stefanie Mott, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Complementary Medicine Research|July 30, 2023
Improvement of Spinocerebellar Ataxia 3 Symptoms Treated with Eurythmy Therapy: A Case VignetteKatharina Gerlach
Complementary Therapies in Medicine|May 26, 2019
Development of a documentation instrument for movement-orientated Mind-Body-Therapies taking the example of Eurythmy-TherapyKatharina Gerlach, Daniela Rodrigues Recchia, Arndt Büssing
Tissue Barriers|April 4, 2015
IL-9 regulates intestinal barrier function in experimental T cell-mediated colitisKatharina Gerlach, Andrew N McKenzie, Markus F Neurath, et al.
International Journal of Cancer|June 19, 2013
Nuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerCarolin Daniel, Katharina Gerlach, Martin Väth, et al.
Developmental Psychology|June 27, 2017
The role of morbidity for proxy-reported well-being in the last year of lifeKatharina Gerlach, Nilam Ram, Frank J Infurna, et al.
Nature Protocols|June 2, 2017
Chemically induced mouse models of acute and chronic intestinal inflammationStefan Wirtz, Vanessa Popp, Markus Kindermann, et al.
Cancer Research|June 29, 2012
Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitisKatharina Gerlach, Carolin Daniel, Hans A Lehr, et al.
Plos One|January 18, 2019
FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiationMarlene Steiner, Lucas Schneider, Jasmin Yillah, et al.
Journal of Crohn'S & Colitis|August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammationKatharina Gerlach, Kristina Lechner, Vanessa Popp, et al.
Gastroenterology|September 19, 2016
Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in MiceVanessa Popp, Katharina Gerlach, Stefanie Mott, et al.
Pageof 3